HomeCompareVNTA vs DGRO

VNTA vs DGRO: Dividend Comparison 2026

VNTA yields 4987.53% · DGRO yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VNTA wins by $60726414423802.55M in total portfolio value
10 years
VNTA
VNTA
● Live price
4987.53%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$60726414423802.59M
Annual income
$58,422,163,401,288,310,000.00
Full VNTA calculator →
DGRO
iShares Core Dividend Growth ETF
● Live price
2.13%
Share price
$68.98
Annual div
$1.47
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.6K
Annual income
$239.96
Full DGRO calculator →

Portfolio growth — VNTA vs DGRO

📍 VNTA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVNTADGRO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VNTA + DGRO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VNTA pays
DGRO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VNTA
Annual income on $10K today (after 15% tax)
$423,940.15/yr
After 10yr DRIP, annual income (after tax)
$49,658,838,891,095,065,000.00/yr
DGRO
Annual income on $10K today (after 15% tax)
$181.24/yr
After 10yr DRIP, annual income (after tax)
$203.97/yr
At 15% tax rate, VNTA beats the other by $49,658,838,891,095,065,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VNTA + DGRO for your $10,000?

VNTA: 50%DGRO: 50%
100% DGRO50/50100% VNTA
Portfolio after 10yr
$30363207211901.31M
Annual income
$29,211,081,700,644,155,000.00/yr
Blended yield
96.21%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VNTA buys
0
DGRO buys
0
No recent congressional trades found for VNTA or DGRO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVNTADGRO
Forward yield4987.53%2.13%
Annual dividend / share$2.00$1.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$60726414423802.59M$31.6K
Annual income after 10y$58,422,163,401,288,310,000.00$239.96
Total dividends collected$60570499970588.68M$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: VNTA vs DGRO ($10,000, DRIP)

YearVNTA PortfolioVNTA Income/yrDGRO PortfolioDGRO Income/yrGap
1← crossover$509,453$498,753.12$11,293$213.22+$498.2KVNTA
2$24,291,968$23,746,853.30$12,730$217.32+$24.28MVNTA
3$1,084,224,114$1,058,231,708.37$14,326$221.10+$1084.21MVNTA
4$45,302,256,588$44,142,136,785.73$16,098$224.56+$45302.24MVNTA
5$1,772,207,810,855$1,723,734,396,305.83$18,064$227.74+$1772207.79MVNTA
6$64,916,695,091,411$63,020,432,733,796.11$20,246$230.65+$64916695.07MVNTA
7$2,226,904,004,397,647$2,157,443,140,649,837.00$22,666$233.30+$2226904004.37MVNTA
8$71,550,063,790,460,920$69,167,276,505,755,440.00$25,349$235.73+$71550063790.44MVNTA
9$2,153,505,628,518,013,700$2,076,947,060,262,220,500.00$28,325$237.94+$2153505628517.99MVNTA
10$60,726,414,423,802,585,000$58,422,163,401,288,310,000.00$31,624$239.96+$60726414423802.55MVNTA

VNTA vs DGRO: Complete Analysis 2026

VNTAStock

Ventana Biotech, Inc., a development stage biotech company, identifies, evaluates, acquires, develops, and partners commercialization of intellectual property in the area of drug candidates for personalized medicine. The company focuses in the areas of anti-obesity and related illnesses. The company holds rights for the formula for a medicament containing chewing gum with a composition of the extract of hoodia gordonii and 2-hydroxyoleic acid for the treatment of obesity, hypertension, and other metabolic disorders. The company develops appetite suppressant chewing gums, including the low dosage product for the over-the-counter market and the high dosage product for distribution by pharmacists. It intends to market low dosage product though drug and health food stores. The company was formerly known as Personalica, Inc. and changed its name to Ventana Biotech, Inc. in October 2008. Ventana Biotech, Inc. was founded in 1989 and is based in Butschwil, Switzerland.

Full VNTA Calculator →

DGROETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →
📬

Get this VNTA vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VNTA vs SCHDVNTA vs JEPIVNTA vs OVNTA vs KOVNTA vs MAINVNTA vs VIGVNTA vs NOBLVNTA vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.